Trial intelligence / Profile preview

Comparing Treatment Efficacy With High and Medium Dose of Fluticasone in Combination With Salmeterol in COPD Patients

NCT01131806Phase 4Unknown

Sponsor
Taipei Veterans General Hospital
Start
Dec 2009
Primary completion
Nov 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of fluticasone in chronic obstructive pulmonary disease (COPD), sponsored by Taipei Veterans General Hospital. Status: unknown.

02

Drugs

fluticasone
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT01131806.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01131806.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call